Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
HURCO COMPANIES INCHurco Companies Reports 8% Decline in Sales for Q1 Fiscal 2026
CITIZENS & NORTHERN CORPCitizens & Northern Corporation Reports $23.4 Million Net Income for Fiscal Year 2025
NORTHRIM BANCORP INCNorthrim Bancorp Reports 75% Increase in Net Income for 2025
Drilling Tools International CorpDrilling Tools International Corporation Reports $159.6M Revenue with Net Loss in 2025
Information Services Group Inc.Information Services Group Reports Slight Revenue Decline but Improved Net Income for Fiscal Year 2025
ONE LIBERTY PROPERTIES INCOne Liberty Properties Reports $97.2 Million Revenue for Fiscal Year 2025, Driven by Rental Income Growth
ARROW FINANCIAL CORPArrow Financial Corporation Reports Significant Increase in Net Income and Assets for Fiscal Year 2025
SB FINANCIAL GROUP, INC.SB Financial Group Reports Increased Net Income and Asset Growth for Fiscal Year 2025
Cohen & Co Inc.Cohen & Company Reports 246% Revenue Growth to $275.6 Million in Fiscal Year 2025
CAMDEN NATIONAL CORPCamden National Corp. Reports 23% Increase in Net Income for 2025
Moderna, Inc.Diamond or dud? - MRNA - March 2026
REPUBLIC BANCORP INC /KY/Republic Bancorp Reports 30% Increase in Net Income and 29% Rise in Diluted EPS for 2025
INDEPENDENT BANK CORP /MI/Independent Bank Corporation Reports 10% Revenue Growth and $36.5 Million Net Income for Fiscal Year 2025
JOHN WILEY & SONS, INC.John Wiley & Sons Reports Revenue Increase and Profitability Improvements in Q3 2026
GMTech Inc.GMTech Inc. Reports Revenue Surge to $3.48 Million and Net Income Recovery in 2025
Future Vision II Acquisition Corp.Future Vision II Acquisition Corp. Reports $2.07 Million Net Income for Fiscal Year 2025
Immuneering CorpImmuneering Corporation Reports $56M Net Loss and Operational Updates in 10-K Filing
PMV Pharmaceuticals, Inc.PMV Pharmaceuticals Reports $77.7 Million Net Loss for 2025, Focuses on Rezatapopt Development
Altimmune, Inc.Altimmune Reports $88.1 Million Net Loss for Fiscal Year 2025, Plans Phase 3 Trial for Pemvidutide
MIAMI INTERNATIONAL HOLDINGS, INC.Miami International Holdings Reports 19.6% Revenue Growth but $70M Net Loss for Fiscal Year 2025
Atlantis Glory Inc.Atlantis Glory Inc. Reports No Revenue and Net Loss of $39,199 for Fiscal Year 2025
Traeger, Inc.Traeger, Inc. Reports 7.4% Revenue Decline and $115.2 Million Net Loss for Fiscal Year 2025
Oxford Square Capital Corp.Oxford Square Capital Corp. Reports Financial Results for Fiscal Year 2025
MARKETWISE, INC.MarketWise Reports 19.7% Revenue Decline and Subscriber Drop for Fiscal Year 2025
NewLake Capital Partners, Inc.NewLake Capital Partners Reports $51.1 Million Revenue for Fiscal Year 2025